Search

everythinglearnresearchcommunity

for

Search:↓

Pranic meditation significantly improved mental health and quality of life for breast cancer survivors.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Chemotherapy can cause significant hair thinning and changes in hair texture, while tamoxifen has a smaller effect.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

Chemotherapy worsens nutritional status in breast cancer patients, requiring targeted nutritional strategies.

Xiaoaiping reduces chemotherapy side effects and improves quality of life for breast cancer patients.

The new drug carriers show promise for better targeting and treating ovarian cancer.

Cancer development is like natural selection, involving mutated cells and environmental factors.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

Epithelial stem cells are crucial for tissue renewal and repair, and understanding them could improve treatments for damage and cancer.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Stem cell plasticity is crucial for wound healing but can also contribute to cancer development.

Finasteride for hair loss may increase the risk of certain cancers and has side effects; better regulation and education on its use are needed.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

Women with PCOS may have a reduced ability to fight breast tumor cells over time.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

A new protein was made to detect specific skin cell growth receptors and worked in normal skin but not in skin cancer cells.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

Oncoplastic breast surgery is more cost-effective than standard lumpectomy for large-breasted women despite being more expensive.